FT
WST icon

Fiduciary Trust’s West Pharmaceutical WST Stock Holding History

Fiduciary Trust’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$473K Sell
1,318
-223
-14% -$68.2K 0.01% 622
2026
Q1 		$386K Buy
1,541
+21
+1% +$5.22K ﹤0.01% 663
2025
Q4 		$418K Buy
+1,520
New +$416K ﹤0.01% 619
2025
Q2 		– Sell
-1,158
Closed -$259K – 863
2025
Q1 		$259K Sell
1,158
-338
-23% -$93.2K ﹤0.01% 704
2024
Q4 		$490K Buy
1,496
+10
+0.7% +$3.15K 0.01% 480
2024
Q3 		$446K Buy
1,486
+204
+16% +$62.5K 0.01% 484
2024
Q2 		$422K Sell
1,282
-25
-2% -$8.84K 0.01% 477
2024
Q1 		$517K Buy
1,307
+31
+2% +$11.5K 0.01% 454
2023
Q4 		$449K Hold
1,276
– – 0.01% 464
2023
Q3 		$479K Hold
1,276
– – 0.01% 447
2023
Q2 		$488K Hold
1,276
– – 0.01% 447
2023
Q1 		$442K Sell
1,276
-90
-7% -$26.3K 0.01% 463
2022
Q4 		$321K Buy
1,366
+400
+41% +$94.8K 0.01% 525
2022
Q3 		$238K Sell
966
-35
-3% -$10.7K 0.01% 564
2022
Q2 		$303K Buy
1,001
+263
+36% +$85.6K 0.01% 540
2022
Q1 		$303K Buy
738
+25
+4% +$9.79K 0.01% 565
2021
Q4 		$334K Buy
713
+53
+8% +$22.8K 0.01% 542
2021
Q3 		$280K Buy
660
+5
+0.8% +$2.11K 0.01% 571
2021
Q2 		$235K Buy
+655
New +$216K ﹤0.01% 591

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Fiduciary Trust's WST Position: Q2 2026 in Review

Fiduciary Trust reduced its West Pharmaceutical (WST) stake by 14% in Q2 2026, selling an estimated $68.2K and leaving 1,318 shares worth $473K. The position accounts for 0.01% of the portfolio, ranked #622.

Fiduciary Trust first reported a position in WST in Q2 2021 and has held it in 19 quarters since. The position peaked at $517K in Q1 2024. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Fiduciary Trust held 1,318 shares of West Pharmaceutical worth $473K as of Q2 2026.
  • Fiduciary Trust sold 223 West Pharmaceutical shares in Q2 2026, an estimated $68.2K.
  • West Pharmaceutical made up 0.01% of Fiduciary Trust's portfolio in Q2 2026, its #622 holding.
  • Fiduciary Trust first reported a position in West Pharmaceutical in Q2 2021 and has held it in 19 quarters since.
  • Fiduciary Trust's West Pharmaceutical position peaked at $517K in Q1 2024.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.